Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|5|2|109-117

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.5, Iss.2, 2010-01, pp. : 109-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incretin Mimetics Target Novel Pathways to Treat Type 2 Diabetes

By  

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 4, 2004-09 ,pp. : 18-22

Adis International

Access to resources Recommend Favorite

Incretin for the continuing treatment of secondary failure to metformin in Type 2 diabetes

By Gallwitz Baptist  

Diabetes Management, Vol. 3, Iss. 4, 2013-07 ,pp. : 323-331

Future Medicine

Access to resources Recommend Favorite

Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus

By Landgraf R.  

Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. : 411-425

Adis International

Access to resources Recommend Favorite

Alzheimer's Disease and Type 2 Diabetes: What Is the Connection?

By  

The Consultant Pharmacist, Vol. 30, Iss. 2, 2015-02 ,pp. : 112-115

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

The incretin system in the management of type 2 diabetes mellitus

By Stephens Jeffrey W  

Clinical Medicine, Vol. 10, Iss. 5, 2010-10 ,pp. : 491-495

Royal College Of Physicians

Access to resources Recommend Favorite